GlassScriptPhysician profile
Amit Revanasiddappa Hudgi
NPI 1649830175
$3,244.37
in general payments reported to CMS, 2019-2025
15 companies · $433 in 2025
The $433 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.84 · 2022: $93.44 · 2023: $2,548 · 2024: $155 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,960 · Food and Beverage: $1,176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,959.73 |
| Food and Beverage | $1,176.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wilson Cook Medical Incorporated | $1,556.80 | 2023 | Hemospray, Fusion |
| Cook Medical LLC | $499.64 | 2023 | Hemospray, Echotip |
| Abbvie INC. | $225.27 | 2023-2025 | |
| Laborie Medical Technologies Corp. | $197.69 | 2025 | |
| Phathom Pharmaceuticals, INC. | $169.46 | 2024-2025 | Voquezna |
| Boston Scientific Corporation | $133.93 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.32 | 2023 | Xifaxan |
| Gi Supply, INC. | $93.44 | 2022 | |
| Intercept Pharmaceuticals, INC. | $64.26 | 2023 | Ocaliva |
| Qol Medical, LLC | $55.22 | 2024 | Sucraid |
| Ipsen Biopharmaceuticals, INC | $47.17 | 2025 | Iqirvo |
| Genzyme Corporation | $32.95 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.45 | 2024 | Eohilia |
| Gilead Sciences, INC. | $28.93 | 2025 | Livdelzi |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Hudgi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.